Technical accounting and financial reporting for companies raising capital, going public, and operating in the public markets. The sections below cover the filings and the issues that decide whether your transaction stays on schedule.
We prepare the financial statements, memos, and tie-outs your filing depends on, so the accounting workstream stays off your deal's critical path.
Capital markets advisory: registration forms, comfort letters, and cheap stock
Key takeaways
What it is. The accounting workstream across a registration: which form and which financial statements each requires, the comfort letter and the 135-day rule that time pricing, and cheap stock, the valuation of pre-IPO grants against the offer price.
Where it breaks. Scoping the work off the wrong form loses weeks, a stale 135-day clock pushes a deal to the next quarter, and pre-IPO grants below the offer price draw a comment in nearly every review.
How we help. We scope the financial statements off the form on day one, time the interim review around pricing, and build the cheap-stock support before filing rather than after a comment.
Every capital markets transaction runs through a registration statement, and every registration statement depends on financial statements. The SEC reviews the filing, the auditors comfort the numbers, and the underwriters diligence both. The accounting workstream is on the critical path whether anyone planned it that way or not.
We have prepared companies for these filings and audited them under PCAOB standards, so we know what reviewers comment on and what auditors test. The issues below are the recurring ones across S-1s, F-1s, S-4s, F-4s, and Super 8-Ks, each with the answer and what we do about it.
The form decision
Which registration form, and which financials
The form your transaction uses decides the financial statements, pro formas, and audit standard, and scoping off the wrong form is a common way to lose weeks. Form S-1 is the domestic IPO (issuer US GAAP, three years or two for EGCs, plus interim); Form F-1 is its foreign private issuer counterpart, where IFRS as issued by the IASB is accepted with no US GAAP reconciliation; Form S-4 registers mergers, exchange offers, and most de-SPACs, carrying both companies’ statements plus Article 11 pro formas and doubling as the proxy; Form F-4 is the S-4 for a foreign private issuer; and the Super 8-K carries Form 10 disclosure and audited target financials within four business days of a shell-company combination. The registrant’s own statements are always a PCAOB audit, but an acquired business’s statements under Rule 3-05 may be audited under AICPA GAAS or PCAOB, unless the target is a predecessor, as in a de-SPAC, which requires PCAOB.
The registration forms and their financial statement requirements. Illustrative.
Pricing week
Pricing and closing: the comfort letter and the 135-day clock
At pricing, the underwriters require a comfort letter from the auditors to support their Section 11 due diligence defense, and a bring-down letter follows at closing; without it, the deal does not price. Under AS 6101 (the former SAS 72) the letter gives negative assurance on subsequent changes in specified financial-statement items, but only if its cut-off date is within 135 days of the last audited or reviewed balance-sheet date. Past that, an interim review has to reset the clock before you can price, which is why the review timing is planned before the roadshow. Audited and reviewed figures and the numbers that tie to them get that assurance; non-GAAP measures and operating metrics get agreed-upon procedures at best.
Why the comfort letter exists, and the 135-day clock that times pricing. Illustrative.
Cheap stock
Cheap stock: valuing your pre-IPO grants
Options granted in the year or two before an IPO, at prices below the eventual offer, draw a recurring comment: were they undervalued, understating stock-compensation expense? The staff expects contemporaneous valuation work behind each grant. Keep a 409A valuation for every grant in the twelve to eighteen months before the offering, and be able to walk each grant-date value up to the offer price through the facts that changed in between: milestones achieved, comparable-company movement, the rising probability of an IPO, and the marketability discount shrinking as liquidity nears. Where a grant-date value cannot be supported, the correction is additional stock-compensation expense under ASC 718, recorded before filing rather than restated after a comment, with the methodology explained in the MD&A critical estimates.
How a pre-IPO grant value reaches the offer price, and the ASC 718 correction. Illustrative.
This is for you if
You are preparing an S-1, F-1, S-4, or F-4 and need the financial statements and support scoped to the form.
Your deal calendar is at risk from audit timing, staleness dates, or an open accounting issue.
The SEC commented on your filing and the response needs technical analysis beyond drafting.
You just priced or closed and the first 10-Q is weeks away.
What you get
Filing-ready financial statements S-1, F-1, S-4, F-4, and Super 8-K financial statements, footnotes, and schedules built to Regulation S-X.
Registration statement support MD&A drafting, pro formas with adjustment notes, and the critical estimates disclosure written from the memos.
Comfort letter and tie-out packages Circle-ups, tie-outs, and review timing coordinated so pricing week is mechanical.
Deal-calendar management The filing calendar built off staleness dates, with the close process managed to it.
How We Help
What we deliver
On a capital markets engagement, you get the documents the filing and the deal actually depend on.
Filing-ready financial statementsS-1, F-1, S-4, F-4, and Super 8-K financial statements, footnotes, and schedules built to Regulation S-X.
Registration statement supportMD&A drafting, pro formas with adjustment notes, and the critical estimates disclosure written from the memos.
Comfort letter and tie-out packagesCircle-ups, tie-outs, and review timing coordinated so pricing week is mechanical.
Deal-calendar managementThe filing calendar built off staleness dates, with the close process managed to it.
When companies bring us in
You are preparing an S-1, F-1, S-4, or F-4 and need the financial statements and support scoped to the form.
Your deal calendar is at risk from audit timing, staleness dates, or an open accounting issue.
The SEC commented on your filing and the response needs technical analysis beyond drafting.
You just priced or closed and the first 10-Q is weeks away.
Our Experience
Where we have done this work
Engagement Notes
Traditional IPO: digital advertising platform
S-1 support for a content recommendation and advertising technology company through its Nasdaq IPO: gross-versus-net revenue presentation for traffic acquisition costs, the cheap stock valuation support, circle-up and comfort letter support through pricing, and the first 10-Q on public-company timelines.
Engagement Notes
Alternative paths: reverse merger and SPAC combinations
Reporting support for companies entering the public markets without a traditional IPO: a streaming television company through a reverse merger, with recast financial statements and Form 10 level disclosure on the closing clock, and a small modular reactor company through a SPAC combination, with S-4 financials and multi-scenario pro formas for a pre-revenue business.
The Detail
The gaps, and how we close each one
Issue 01
The registration forms: which one, which financialsS-1 / F-1 / S-4 / F-4 / 8-K
The form your transaction uses determines the financial statements, pro formas, and audit standard required, and teams routinely scope the work off the wrong form. A traditional IPO, a merger, a foreign private issuer, and a de-SPAC each take a different path through the rules.
The treatment
Form S-1 is the domestic IPO registration statement: audited annual financial statements, unaudited interim stubs, MD&A, and full Regulation S-X compliance. Form F-1 is its foreign private issuer counterpart, permitting IFRS as issued by the IASB without US GAAP reconciliation. Form S-4 registers securities issued in mergers and exchange offers, including most de-SPAC combinations: it carries financial statements of both companies plus Article 11 pro formas, and doubles as the proxy statement in a merger vote. Form F-4 is the S-4 for foreign private issuers. The Super 8-K is not a registration statement but does a registration statement’s work: within four business days of closing a shell-company combination, it must carry Form 10 level disclosure, including audited target financials and pro formas. The registrant’s own financial statements are audited under PCAOB standards by a registered firm; the financial statements of an acquired business under Rule 3-05 may be audited under AICPA GAAS or PCAOB standards per the SEC Financial Reporting Manual, unless the target is or will be a predecessor, as in a de-SPAC, in which case PCAOB standards are required. Scope the financial statement requirements off the form on day one, because each form has its own periods, staleness windows, and content requirements.
What we do: We write the form and financial statement requirements memo on day one of the engagement, so the workplan is scoped to the right filing.
From our engagements: The scoping conversation we have most often: a team six weeks from filing discovers the form requires a period, a pro forma, or an acquired-business financial statement nobody planned for. The form memo on day one prevents it.
Issue 02
Age of financial statements: the staleness deadlineReg S-X 3-12
Registration statements cannot go effective on stale financial statements, and the staleness windows drive the entire deal calendar. Miss a window and the transaction waits for the next set of financials, which in practice can slip a deal by a full quarter.
The treatment
Regulation S-X 3-12 sets the timing: audited annual financial statements and the most recent required interim period must be fresh at effectiveness, with interim statements generally going stale on a 134-day cycle (and tighter rules around year-end). Emerging growth companies may present two years of audited financials instead of three in an IPO, a real cost saver, and can omit periods from draft submissions they reasonably believe will not be required at launch. Acquisitions add S-X 3-05: significant acquired businesses require their own audited financial statements, with significance measured on investment, asset, and income tests and a maximum of two years required post-2020 amendments. Build the filing calendar backward from the staleness dates, including the quarter you will be in at pricing, then hold the close process to it. The calendar is an accounting document as much as a banking one.
What we do: We build the filing calendar backward from the staleness dates and manage the close process to it.
Issue 03
Cheap stock: the comment you should expectASC 718
The SEC staff compares your pre-IPO option grants to the offering price in nearly every IPO review. A grant at $4 twelve months before a $16 offering draws a question: was it undervalued, understating stock-compensation expense? The answer the staff expects is contemporaneous valuation work behind each grant.
The treatment
Maintain a contemporaneous 409A valuation for every grant in roughly the twelve to eighteen months before the offering, and be able to walk each grant-date value up to the anticipated offering price through the facts that changed in between: milestones achieved, comparable-company movements, a heavier probability-of-IPO weighting, and the marketability discount shrinking as liquidity nears. Where a grant-date value cannot be supported, the correction is additional stock compensation expense, better recognized before filing than restated after a comment. The disclosure side matters too: MD&A critical estimates should explain the valuation methodology and the drivers of the increase to the offering price. Companies that file with the valuation work already done typically clear the comment in one response letter.
What we do: We build the grant-by-grant bridge to the offering price and draft the MD&A valuation disclosure before the staff asks.
In a live transaction with one of these open? Talk to us this week, not after the next draft.
Underwriters require comfort letters from the auditors on every underwritten offering, and the letter’s scope depends on preparation the company controls: what is circled in the prospectus, what supports each number, and how recently the interim financials were reviewed.
The treatment
Comfort letters under AS 6101 give negative assurance on changes in specified financial statement items after the latest period, but that assurance is only available within 135 days of the most recent audited or reviewed period, which is why the timing of interim reviews is planned around pricing, not the other way around. Every circled number in the offering document needs a tie-out package: the schedule that supports it, reconciled to the audited financials or the accounting records. Non-GAAP measures and operating metrics get agreed-upon procedures at best, so decide early what the underwriters will ask to have comforted. We build the circle-up support as the document is drafted; retrofitting tie-outs during the pricing week is how deals lose days.
What we do: We prepare the circle-up and tie-out packages as the document is drafted and coordinate the review timing so negative assurance is available at pricing.
From our engagements: Our comfort letter work includes the procedural edge cases, like which parties are entitled to receive a letter and what representations they owe under AS 6101, on live underwritten offerings.
Issue 05
Pro forma financial informationArticle 11
Mergers, significant acquisitions, and de-SPACs require Article 11 pro forma financial statements: the combined company as if the transaction had already happened. The 2021 amendments rewrote the adjustment model, and pro formas drafted from old templates draw comments.
The treatment
Article 11 now permits two adjustment columns: transaction accounting adjustments, which reflect the required accounting for the transaction (purchase accounting, financing, redemptions), and optional autonomous entity adjustments for spin-offs. Forward-looking synergies live only in an optional, clearly separated management’s adjustments presentation with strict conditions. For a de-SPAC, the pro formas typically present multiple redemption scenarios, reflect the reverse recapitalization, and reconcile share counts to the merger agreement. Every adjustment needs a note explaining the calculation, and the columns must tie to the historical statements included elsewhere in the filing. Draft the pro formas with the transaction accounting memo open, because the two documents must agree.
What we do: We prepare the Article 11 pro formas and adjustment notes so they tie to the historical statements and the transaction accounting memo.
Issue 06
The first quarter as a public companyExchange Act
Effectiveness is the start line, not the finish. The first 10-Q lands on a statutory deadline weeks after listing, with reviewed interim financials, full footnotes, MD&A, and certifications, produced by a team that has never run a public close.
The treatment
Stand up the quarterly reporting process before pricing: a close calendar with owners and dates that hits the filing deadline with review time to spare, a disclosure checklist mapped to the interim requirements, auditor review procedures scheduled, EPS mechanics (including any exchange ratio or IPO-driven share changes) automated, and 302 certification support for the officers signing. The first quarter also inherits everything the S-1 promised: segment presentation, non-GAAP definitions, and critical estimates must match the registration statement or explain the change. Companies that treat the first 10-Q as a continuation of the S-1 process file cleanly; companies that disband the IPO team at pricing do not.
What we do: We stand up the close calendar, disclosure checklist, and certification support before pricing, and run the first quarters with you.
FAQ
Frequently asked questions
When should we engage a capital markets advisor?
Twelve to eighteen months before a planned transaction is ideal. That window allows time to remediate gaps in controls, systems, and reporting before the auditors and the SEC examine them. We also join transactions already in flight when companies hit accounting issues mid-process.
Do you replace our auditor or work alongside them?
We work alongside them, on your side of the table. Independence rules prevent your auditor from preparing the financial statements and analyses they audit. We prepare the workpapers, memos, and schedules; your auditor tests them.
What makes SEC reporting different from private company reporting?
Scope, precision, and deadlines. Public filings require Regulation S-X compliant statements, expanded footnotes, MD&A, and XBRL tagging, filed on fixed statutory deadlines. The disclosure standard is higher and the tolerance for error is effectively zero.
Can you support both US GAAP and IFRS filers?
Yes. We support domestic registrants under US GAAP and foreign private issuers filing IFRS financial statements, including IFRS-to-US GAAP reconciliations where required.
How do fees work for capital markets engagements?
Fixed fees tied to a defined scope. Simpler projects start around $50,000; full readiness engagements for larger companies run significantly more. We scope precisely after a discovery call so there are no surprises.
Sources & authorities
Primary sources for this page
Regulation S-X, financial statements in a registration statement.Rules 3-01 and 3-02: the registrant’s required periods.
Age of financial statements.Regulation S-X Rule 3-12: the staleness windows that drive the deal calendar.
Financial statements of acquired businesses.Regulation S-X Rule 3-05, on the significance tests.
Pro forma financial information.Regulation S-X Article 11: transaction accounting and autonomous-entity adjustments.
Comfort letters.PCAOB AS 6101 (the former SAS 72): negative assurance and the 135-day rule.
Foreign private issuers.The FPI definition: who files on the F-series and may use IFRS as issued by the IASB without a US GAAP reconciliation.
Current reports.Form 8-K Item 2.01: the Super 8-K disclosure within four business days of a shell-company combination.
Stock compensation and cheap stock. ASC 718: the fair value of pre-IPO grants and the bridge to the offer price.
This page summarizes SEC rules and staff guidance for general information, and is not accounting or legal advice. Rules change; confirm the current text before you rely on it.